Pictet Alternative Advisors (PAA), the Pictet Group’s wholly owned alternative investment business, has announced the launch of a second thematic private equity strategy, exclusively focused on health investments.
The strategy complements PAA’s existing thematic private equity franchise, initiated with the successful fundraising of its first fund dedicated to technology, which has been closed at a hard cap of USD350 million in September 2021.
The new strategy aims to invest in best-in-class biotech and healthcare-focused VC, Growth, and PE funds globally and will dedicate a substantial allocation to co-investments within its covered segments of high conviction.
